Global Vaccines Innovation and Immunology Conference

Every advancement in vaccine science contributes to stronger healthcare systems and better protection against infectious diseases. The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) offers an international platform for scientific exchange from September 21–23, 2026, in London, United Kingdom, with hybrid and virtual participation available for attendees worldwide.
The Vaccine Conference 2026 welcomes immunologists, vaccinologists, clinicians, microbiologists, pharmaceutical researchers, biotechnology professionals, public health specialists, laboratory scientists, educators, and students interested in the latest developments across immunological research. Participants will explore innovative approaches in vaccine discovery, immune modulation, translational medicine, therapeutic antibodies, immunogenetics, clinical trials, vaccine manufacturing, infectious disease prevention, and personalized immunotherapy.
Scientific presentations will be complemented by discussions that encourage knowledge sharing between universities, hospitals, research institutes, pharmaceutical companies, biotechnology organizations, and healthcare agencies. These interactions create valuable opportunities for collaborative investigations, academic partnerships, and professional networking across multiple disciplines.
Through its digital platform, remote participants can access keynote lectures, research presentations, educational sessions, and interactive discussions from anywhere in the world. This accessible Immunology Congress format supports continuous learning while connecting experts beyond geographical boundaries.
Immunization Conferences encourages innovation, scientific excellence, and international cooperation, making it an ideal destination for professionals seeking to expand expertise, discover emerging research, and contribute to future advances in vaccines and immunology.